HM Payson & Co. Lowers Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

HM Payson & Co. cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 8,582 shares of the medical equipment provider’s stock after selling 315 shares during the period. HM Payson & Co.’s holdings in Intuitive Surgical were worth $4,479,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Howard Capital Management Group LLC grew its holdings in shares of Intuitive Surgical by 4.5% in the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after purchasing an additional 92 shares in the last quarter. Avidian Wealth Enterprises LLC grew its stake in shares of Intuitive Surgical by 7.0% in the third quarter. Avidian Wealth Enterprises LLC now owns 656 shares of the medical equipment provider’s stock worth $322,000 after acquiring an additional 43 shares in the last quarter. Graypoint LLC grew its stake in shares of Intuitive Surgical by 7.5% in the third quarter. Graypoint LLC now owns 2,496 shares of the medical equipment provider’s stock worth $1,226,000 after acquiring an additional 175 shares in the last quarter. Principal Financial Group Inc. increased its position in shares of Intuitive Surgical by 1.5% during the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after acquiring an additional 9,194 shares during the period. Finally, Consolidated Planning Corp boosted its holdings in Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on ISRG shares. UBS Group upped their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Leerink Partners lifted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Piper Sandler reiterated an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Trading Down 3.8 %

Shares of NASDAQ ISRG opened at $518.26 on Friday. The stock has a market cap of $184.59 billion, a P/E ratio of 80.85, a P/E/G ratio of 5.85 and a beta of 1.43. The stock has a 50 day moving average of $571.36 and a two-hundred day moving average of $531.20. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 489 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $533.18, for a total transaction of $260,725.02. Following the transaction, the senior vice president now owns 2,091 shares of the company’s stock, valued at $1,114,879.38. This trade represents a 18.95 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,579 shares of company stock worth $7,756,844 in the last 90 days. 0.90% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.